The results of their meta-analysis indicated that the combination of UMSCs and TST had more satisfied therapeutic effects for LC patients than TST alone (improved liver function is shown by reduced total bilirubin, alanine aminotransferase, prothrombin time, increased serum albumin, cholinesterase, and prothrombin activity). Here, F2 is linked to laryngotracheoesophageal cleft.